TEVA


Teva to Pay $225M to Settle Texas’ Opioid-Related Claims

This article was originally published on TipRanks.com.

Teva to Pay $420M to Settle Shareholders’ Generic Drug Pricing Lawsuit — Report

This article was originally published on TipRanks.com.

Teva Found Guilty of Fueling New York Opioid Crisis

This article was originally published on TipRanks.com New York jurors have held Teva Pharmaceuticals, a U.

Teva Partners with Tikun Olam-Cannbit to Sell Medical Cannabis Products – Report

This article was originally published on TipRanks.com.

Teva Launches First Generic of Naloxone Hydrochloride Nasal Spray in the U.S.

This article was originally published on TipRanks.com.

Teva’s Seffalair And BroPair Spiromax Receive Approval In EU

Teva Pharmaceuticals Europe has received marketing authorization for Seffalair and BroPair Spiromax in the European Union to treat asthma. The drugs have been …

Teva Launches Two Digital Inhalers For Asthma Patients

Teva Pharmaceutical Industries launched two new digital inhalers AirDuo Digihaler and ArmonAir Digihaler in the US for patients with Asthma. With these two …

Barclays Has New Plays for Healthcare Fans

Investment banker Barclays announced it has initiated coverage of 20 U.S.

Teva Stock Slips on Back of Weak 2019 Outlook; Analysts Weigh In

You know there was some bad news with a company’s quarterly update when the stock tanks after the results are announced. That’s what …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts